Clincosm LogoSign in Get a demo

Colorectal Cancer

Showing NaN - NaN of 72
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Brussels, Barcelona, Madrid (JK08)

Recruiting
  • Cancer
  • +6 more
  • Brussels, Belgium
  • +3 more
Jan 30, 2023

Pancreatic Cancer, Colorectal Cancer, NSCLC Trial in Worldwide (AMG820 and pembrolizumab)

Completed
Has Results
  • Pancreatic Cancer
  • +2 more
  • AMG820 and pembrolizumab
  • Atlanta, Georgia
  • +14 more
Jan 18, 2023

NSCLC, Colorectal Cancer, Advanced Solid Tumors Trial in Worldwide (GDC-6036, Atezolizumab, Cetuximab)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Duarte, California
  • +68 more
Jan 10, 2023

Colorectal Cancer, Colorectal Cancer Stage I Trial in Worldwide (E-learning module)

Recruiting
  • Colorectal Cancer
  • Colorectal Cancer Stage I
  • E-learning module
  • Chapel Hill, North Carolina
  • +11 more
Dec 15, 2022

Colorectal Cancer, NSCLC, Triple Negative Breast Cancer Trial in Spain, United Kingdom, United States (GEN1029

Terminated
Has Results
  • Colorectal Cancer
  • +6 more
  • GEN1029 (HexaBody®-DR5/DR5)
  • New Haven, Connecticut
  • +5 more
Nov 11, 2022

Oesophageal Squamous Cell Carcinoma, Gastric Cancer, Hepatocellular Carcinoma Trial in Worldwide (THOR-707, Pembrolizumab,

Active, not recruiting
  • Oesophageal Squamous Cell Carcinoma
  • +4 more
  • Duarte, California
  • +39 more
Oct 31, 2022

Advanced Solid Tumors, Colorectal Cancer, Non Small Cell Lung Cancer Trial in France, Spain (CAN04 (nadunolimab), mFOLFOX, DTX)

Active, not recruiting
  • Advanced Solid Tumors
  • +3 more
  • CAN04 (nadunolimab)
  • +3 more
  • Saint-Herblain, Boulevard Jacques Monod, France
  • +5 more
Oct 20, 2022

Colorectal Cancer Trial in Worldwide (favezelimab/pembrolizumab, regorafenib, TAS-102)

Active, not recruiting
  • Colorectal Cancer
  • favezelimab/pembrolizumab
  • +2 more
  • Washington, District of Columbia
  • +151 more
Oct 12, 2022

Breast Cancer, Cholangiocarcinoma, Colorectal Cancer Trial in Worldwide (Entrectinib)

Recruiting
  • Breast Cancer
  • +15 more
  • Goodyear, Arizona
  • +146 more
Aug 24, 2022

Colorectal Cancer Trial in Worldwide (Obinutuzumab, Atezolizumab, Cibisatamab)

Active, not recruiting
  • Colorectal Cancer
  • Los Angeles, California
  • +12 more
Aug 19, 2022

Advanced Solid Tumors, Triple Negative Breast Cancer, Ovarian Cancer Trial in Worldwide (Pembrolizumab, Lenvatinib)

Active, not recruiting
  • Advanced Solid Tumors
  • +7 more
  • Duarte, California
  • +87 more
Aug 19, 2022

Tumor Malignant, Renal Cell Carcinoma, Hormone Receptor Positive Breast Carcinoma Trial in Worldwide (XL092, Atezolizumab,

Recruiting
  • Neoplasm Malignant
  • +5 more
  • Duarte, California
  • +55 more
Aug 17, 2022

Colorectal Cancer Trial in Worldwide (Pembrolizumab, Pembrolizumab/Quavonlimab, Pembrolizumab/Favezelimab)

Recruiting
  • Colorectal Cancer
  • Pembrolizumab
  • +4 more
  • Orange City, Florida
  • +54 more
Aug 17, 2022

Colorectal Cancer Trial in Australia, Spain, United States (BLYG8824A)

Recruiting
  • Colorectal Cancer
  • Duarte, California
  • +5 more
Aug 2, 2022

Colorectal Cancer Trial in Japan, Spain, United States (M9140)

Recruiting
  • Colorectal Cancer
  • Houston, Texas
  • +4 more
Jul 15, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022

Ovarian Cancer, Bladder Cancer, Non Small Cell Lung Cancer Trial in Worldwide (INCB106385, INCMGA00012)

Recruiting
  • Ovarian Cancer
  • +10 more
  • West Hollywood, California
  • +27 more
Jun 27, 2022

Colorectal Cancer, Colorectal Tumors, Colorectal Carcinoma Trial in Worldwide (Nivolumab, Trametinib, Ipilimumab)

Recruiting
  • Colorectal Cancer
  • +3 more
  • Nivolumab
  • +3 more
  • Birmingham, Alabama
  • +101 more
Jun 13, 2022

Colorectal Cancer Trial in Worldwide (Napabucasin, Fluorouracil, Leucovorin)

Completed
Has Results
  • Colorectal Cancer
  • Birmingham, Alabama
  • +210 more
Mar 30, 2022

Colorectal Cancer Trial in Worldwide (Nivolumab, Oxaliplatin, Leucovorin)

Active, not recruiting
Has Results
  • Colorectal Cancer
  • Nivolumab
  • +4 more
  • Birmingham, Alabama
  • +48 more
Mar 2, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (5 µmol/kg), Placebo)

Terminated
Has Results
  • Colorectal Cancer
  • Chemotherapy-induced Peripheral Neuropathy
  • Calmangafodipir (5 µmol/kg)
  • Placebo
  • Aalst, Belgium
  • +64 more
Nov 19, 2021

Breast Cancer, Colorectal Cancer, Adenoid Cystic Carcinoma Trial in Worldwide (CB-103)

Recruiting
  • Breast Cancer
  • +7 more
  • Santa Monica, California
  • +19 more
Jan 6, 2022

Colorectal Cancer, Chemo-induced Peripheral Neuropathy Trial in Worldwide (Calmangafodipir (2 µmol/kg), Calmangafodipir (5

Terminated
Has Results
  • Colorectal Cancer
  • Chemotherapy-induced Peripheral Neuropathy
  • Calmangafodipir (2 µmol/kg)
  • +2 more
  • Fresno, California
  • +97 more
Nov 19, 2021

Quality of Life, Physical Exercise, Motivation Trial in Elche, Madrid (Physical activity)

Recruiting
  • Quality of Life
  • +4 more
  • Physical activity
  • Elche, Elche/Alicante, Spain
  • +1 more
Sep 28, 2021